N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide

C35H32Cl3N3O4 — CID 6689060

IUPACN-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide
SMILESC[C@@H]1[C@H](Cn2cnc3ccccc32)O[C@H](c2ccc(-c3ccccc3CNC(=O)C(Cl)(Cl)Cl)cc2)O[C@@H]1c1ccc(CO)cc1
InChIInChI=1S/C35H32Cl3N3O4/c1-22-31(19-41-21-40-29-8-4-5-9-30(29)41)44-33(45-32(22)25-12-10-23(20-42)11-13-25)26-16-14-24(15-17-26)28-7-3-2-6-27(28)18-39-34(43)35(36,37)38/h2-17,21-22,31-33,42H,18-20H2,1H3,(H,39,43)/t22-,31+,32+,33+/m1/s1
InChIKeyPZBGEJIYWJLPEI-OEHJXGRSSA-N
MW665.02 g/mol
LogP7.67
Rot. Bonds8

About N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide

N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide (PubChem CID 6689060) has the molecular formula C35H32Cl3N3O4 and a molecular weight of 665.02 g/mol. Its IUPAC name is N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide.

Molecular Properties

Compound NameN-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide
PubChem CID6689060
Molecular FormulaC35H32Cl3N3O4
Molecular Weight665.02 g/mol
Exact Mass663.15
IUPAC NameN-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide
SMILESC[C@@H]1[C@H](Cn2cnc3ccccc32)O[C@H](c2ccc(-c3ccccc3CNC(=O)C(Cl)(Cl)Cl)cc2)O[C@@H]1c1ccc(CO)cc1
InChIInChI=1S/C35H32Cl3N3O4/c1-22-31(19-41-21-40-29-8-4-5-9-30(29)41)44-33(45-32(22)25-12-10-23(20-42)11-13-25)26-16-14-24(15-17-26)28-7-3-2-6-27(28)18-39-34(43)35(36,37)38/h2-17,21-22,31-33,42H,18-20H2,1H3,(H,39,43)/t22-,31+,32+,33+/m1/s1
InChIKeyPZBGEJIYWJLPEI-OEHJXGRSSA-N
XLogP7.67
TPSA85.61 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500665.02
LogP ≤ 57.67
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide?
The IUPAC name of N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide (CID 6689060) is N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide.
What is the SMILES notation for N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide?
The canonical SMILES for N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide is C[C@@H]1[C@H](Cn2cnc3ccccc32)O[C@H](c2ccc(-c3ccccc3CNC(=O)C(Cl)(Cl)Cl)cc2)O[C@@H]1c1ccc(CO)cc1.
What is the InChIKey of N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide?
The InChIKey is PZBGEJIYWJLPEI-OEHJXGRSSA-N. The full InChI is InChI=1S/C35H32Cl3N3O4/c1-22-31(19-41-21-40-29-8-4-5-9-30(29)41)44-33(45-32(22)25-12-10-23(20-42)11-13-25)26-16-14-24(15-17-26)28-7-3-2-6-27(28)18-39-34(43)35(36,37)38/h2-17,21-22,31-33,42H,18-20H2,1H3,(H,39,43)/t22-,31+,32+,33+/m1/s1.
What are the key properties of N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide?
N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide has a molecular weight of 665.02 g/mol, XLogP of 7.67, 8 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[2-[4-[(2R,4R,5S,6S)-4-(benzimidazol-1-ylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]-2,2,2-trichloroacetamide is sourced from PubChem (CID 6689060), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).